Repligen Corporation (RGEN) Social Stream



Repligen Corporation (RGEN): $125.62

0.32 (-0.25%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add RGEN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#216 of 351

in industry

REPLIGEN CORP (RGEN) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering RGEN.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-02 10 $368 $240 $312.555 $171.63 82.11%
2021-12-20 10 $368 $240 $315.888 $171.63 84.05%
2022-02-18 10 $368 $210 $290.333 $171.63 69.16%
2022-03-01 10 $368 $210 $281.444 $171.63 63.98%
2022-04-28 10 $330 $210 $257.666 $171.63 50.13%
2022-06-01 9 $330 $170 $249.888 $171.63 45.6%
2022-07-20 10 $330 $170 $246.888 $171.63 43.85%
2022-08-03 10 $330 $170 $248.555 $171.63 44.82%
2022-09-05 9 $330 $210 $267.444 $171.63 55.83%
2022-10-23 7 $320 $210 $257.125 $171.63 49.81%
2022-10-25 8 $320 $210 $257.125 $171.63 49.81%
2022-11-01 7 $320 $210 $254.625 $171.63 48.36%
2022-11-02 9 $270 $200 $240.5 $171.63 40.13%
2022-12-07 9 $270 $190 $232.111 $171.63 35.24%
2023-01-03 10 $270 $180 $226.9 $171.63 32.2%
2023-02-02 10 $270 $180 $223.9 $171.63 30.46%
2023-02-23 10 $270 $180 $215.8 $171.63 25.74%
2023-03-06 10 $250 $180 $213.8 $171.63 24.57%
2023-03-07 10 $250 $180 $212.8 $171.63 23.99%
2023-04-20 11 $250 $180 $214.363 $171.63 24.9%
2023-05-03 11 $250 $165 $213 $171.63 24.1%
2023-06-01 11 $240 $157 $199.272 $171.63 16.11%
2023-06-28 11 $240 $157 $198.363 $171.63 15.58%
2023-07-06 11 $240 $156 $196.1 $171.63 14.26%
2023-07-21 12 $240 $156 $194.818 $171.63 13.51%
2023-08-01 11 $240 $156 $194.818 $171.63 13.51%
2023-08-02 11 $240 $156 $193 $171.63 12.45%
2023-08-04 11 $240 $156 $193.909 $171.63 12.98%
2023-09-06 12 $240 $165 $196.818 $171.63 14.68%
2023-09-13 12 $240 $165 $196.454 $171.63 14.46%
2023-10-18 13 $240 $165 $197.583 $171.63 15.12%
2023-10-23 13 $240 $165 $195.083 $171.63 13.66%
2023-10-31 13 $240 $158 $193.25 $171.63 12.6%
2023-11-01 13 $210 $158 $186.583 $171.63 8.71%
2023-11-03 13 $210 $148 $181.083 $171.63 5.51%
2023-11-07 13 $210 $148 $176.5 $171.63 2.84%
2023-12-04 13 $210 $148 $175.666 $171.63 2.35%
2023-12-08 13 $210 $148 $175.666 $171.63 2.35%
2023-12-18 13 $210 $148 $176.5 $171.63 2.84%
2023-12-20 13 $210 $148 $178.583 $171.63 4.05%
2023-12-29 13 $210 $148 $181.916 $171.63 5.99%

The Trend in the Analyst Price Target


RGEN's average price target has moved down $128.42 over the prior 23 months.

RGEN reports an average of 19.68% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-05-03 11 250 165 213.000 163.44 30.32%
2023-10-30 13 240 158 193.250 114.17 69.27%
2023-11-17 13 210 148 175.666 150.60 16.64%
2023-11-22 13 210 148 175.666 160.21 9.65%
2023-12-06 13 210 148 175.666 156.20 12.46%

RGEN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.54 9 1 3 0 0 13

The Trend in the Broker Recommendations


Over the past 20 months, RGEN's average broker recommendation rating worsened by 0.32.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RGEN as an investment opportunity.

  • REPLIGEN CORP's average analyst price target is higher than 4536.18% of all US stocks.
  • REPLIGEN CORP's upside potential (average analyst target price relative to current price) is higher than 1327.78% of Pharmaceutical Products stocks.
  • RGEN has a lower variance in analysts' estimates than -1250.36% of Pharmaceutical Products stocks.
  • RGEN has a greater number of analysts covering the stock than 3544.11% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to REPLIGEN CORP are DNA, CGC, and TLRY.

What is the outlook for RGEN? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!